Detalhe da pesquisa
1.
Evidence for Noncanonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-Like Receptor Agonist.
Mol Pharmacol
; 89(4): 457-66, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26843180
2.
Dopamine D4 Receptor-Selective Compounds Reveal Structure-Activity Relationships that Engender Agonist Efficacy.
J Med Chem
; 62(7): 3722-3740, 2019 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30883109
3.
Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D2 Receptor (D2R) Biased Agonism.
J Med Chem
; 60(7): 2890-2907, 2017 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28300398
4.
Toward Understanding the Structural Basis of Partial Agonism at the Dopamine D3 Receptor.
J Med Chem
; 60(2): 580-593, 2017 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27983845
5.
Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D3 Receptor (D3R).
J Med Chem
; 60(4): 1478-1494, 2017 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28186762
6.
Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment.
J Med Chem
; 59(16): 7634-50, 2016 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27508895
7.
Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors.
J Med Chem
; 59(23): 10676-10691, 2016 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27933960